Alligator Bioscience Competitors and Similar CompaniesClear all

Alligator Bioscience's competitors and similar companies include Kiromic Biopharma, Kite Pharma, Dragonfly and Karo Healthcare.
Alligator Bioscience
Alligator Bioscience
Alligator develops antibody-based pharmaceuticals for cancer treatment.
Kiromic Biopharma
Kiromic Biopharma
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
Kite Pharma
Kite Pharma
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
Dragonfly
Dragonfly
Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.
Karo Healthcare
Karo Healthcare
Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.
Founding Date
Founding Date
2001
Founding Date
2012
Founding Date
2009
Founding Date
2015
Founding Date
1987
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Lund, SE HQ
Locations
Houston, US HQ
Locations
Santa Monica, US HQ
Hoofddorp, NL
London, GB
El Segundo, US
Emeryville, US
Frederick, US
Oceanside, US
see more
Locations
Waltham, US HQ
Locations
Stockholm, SE HQ
Stockholm, SE
Employees
Employees
1555% decrease
Employees
4426% increase
Employees
3,9671% decrease
Employees
109
Employees
225
Valuation ($)
Valuation ($)
59 m
Valuation ($)
1.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
kr514k (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
kr3b (FY, 2021)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
kr1.3b (FY, 2021)
Gross profit
Gross profit
kr1.1m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
kr1.7b (FY, 2021)
Net income
Net income
(kr51.4m) (FY, 2025)
Net income
($26.9m) (FY, 2024)
Net income
N/A
Net income
N/A
Net income
(kr17m) (FY, 2021)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 135k
Total funding raised
$ 85.3m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Kiromic Biopharma
HQ
Houston, US
Employees
44↑ 26% increase

Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.

View company
Kite Pharma
HQ
Santa Monica, US

Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.

View company
Dragonfly
HQ
Waltham, US
Employees
109

Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.

View company
Karo Healthcare
HQ
Stockholm, SE

Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.

View company